Posted from: http://www.forbes.com/sites/davechase/2012/07/08/this-could-change-healthtech-startup-funding-forever/ Crowdfunding has had success in high-tech, where people are eager to explore new models. MedStartr is bringing this concept to healthcare where it can be particularly challenging to get a startup off the ground. They have a twist on crowdfunding to address requirements of healthcare, an increasingly popular way to raise capital for startup technologies and interesting projects. MedStartr is like most crowdfunding sites that are non-equity. They have plans later to have an equity model once SEC rules are clarified. In the meantime. MedStartr is attempting to hit the sweet spot that crowdfunding poster child, Pebble Technology hit. That is, customers get a great deal and early access to a product. Meanwhile, the startup gets non-dilutive funding and market validation to help it grow to the next stage.
Stephens had to bootstrap his business and didn’t have the money to advertise. His business flourished because of word of mouth referrals. A successful MedStartr project will have visionary customers be the initial users who can then lead to the first wave of word-of-mouth referrals. Inbound Capital: Inbound Marketing Meet Capital Raising Crowdfunding also borrows principles from Inbound Marketing that have proven to be a game changer for the customer. As Brian Halligan (CEO of Hubspot and his co-founder, Dharmesh Shah coined the term), puts it, when you’re using Inbound Marketing, the thickness of your brain matters a lot more than the thickness of your wallet. For startups with finite money and time, inbound marketing has two key benefits that are critical to an early stage company that realizes that the cheapest form of capital is a product order:
To address the challenges in healthcare, MedStartr has focused on the following items to contrast it with Kickstarter which generally doesn’t accept health related projects:
Partnerships Mitigate Risk for Established Industry Players Large companies receive many new ideas and companies that sound great, but need to be tested and developed further. They may be attractive but often products need to get to the next level to be a viable investment of their time. In the past, there was not much they could do. Now, they can cut a deal such as “get 500 patients and 25 doctors lined up, get their feedback, raise $x,000, and we will give you another $y,000 for the pilot study.” That is exactly what crowdfunding intends to do. It engages the community and provides entrepreneurs with three benefits:
With the partner program industry partners can support the new technologies they believe in, build a customer base, market test, and get great PR all in 45 days or less. In an industry that acted more like railroad companies thannimble tech startups, this is a much-needed shift. MedStartr has already had a major pharma company, medical society and ACO decide to be a launch partner with MedStartr they’ll be announcing in the coming weeks. With the need to reinvent healthcare and the challenge to getting a startup off the ground in the healthcare industry, MedStartr seeks to fill an important market gap. By no means will it replace venture capital, but it can get more companies to that stage of their company’s development. It will be interesting to see how the crowdfunding model takes off in healthcare. If it is any indication, even before launch, project backers found their way into the private beta, resulting in several MedStartrs (that is what the project makers call themselves) alarmingly emailing and tweeting, “We’ve been backed!” and the new catchphrase for those that seek to change the industry with disruptive innovation: “You Back it / We Hack it.” |